Atlanta, GA 5/1/12 (StreetBeat) -- Solos Endoscopy, Inc. (Pinksheets: SNDY) is pleased to announce that the Company expects to show a sales increase of more than 16% as compared to the same period last year when it posts its first quarter financials for period ended March 31, 2012.Solos Endoscopy's sales increased from $84,185 for the period ended March 31, 2011 to $97,760 for the same period this year. Solos management expects the positive trend to continue as the demand for endoscopic instruments has been increasing Worldwide.
Solos Endoscopy has developed several new modifications to its endoscopic instrument lines to accommodate the continual advances in Laparoscopic surgical procedures. The significant advances over the past several years have led to a number of advantages to the patient with laparoscopic surgery versus an open procedure (laparotomy). The demand for endoscope services is increasing due to an increase in the aging and chronically ill population worldwide. Advancements in endoscopic technologies and inclusion of various types of lighting sources, video cameras, real-time conversion of data into three-dimensional images are also driving this market.
Solos Endoscopy expects to post its first quarter financials on the OTC Markets website within the next two weeks. The Company will also be releasing it's "President's Report" for distribution to its shareholders in the next thirty days.
"I am very pleased with the positive turnaround. Solos has been able to reduce its debts and increase its sales in a very short period of time. We believe the Company is well positioned for profitability," stated Bob Segersten, President of Solos Endoscopy, Inc.
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.
Please contact www.thestreetbeat.com for interest in our latest investor relations platform the “CEO Interview Series” with its host Steve Kanaval. The package includes a one-on-one interview with a seasoned industry professional; published segment to our web site with embedded audio/video file; and a compressed file that can be easily e-mailed out to your current and/or potential investors. Please e-mail bflautt@gmail.com or call (662) 392-0740 for pricing and scheduling.
StreetBeat Disclaimer
Thanks for providing this information was of great help for my needs, more information like this is needed,Endoscopy surgery
ReplyDelete